| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/18/2006 | US7078193 Pathogenic Escherichia coli associated protein espA |
| 07/18/2006 | US7078186 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of tumor disorders |
| 07/18/2006 | US7078182 TAO protein kinase polypeptides and methods of use therefor |
| 07/18/2006 | US7078174 Screening methods using SOCS box-containing peptides |
| 07/18/2006 | US7078173 Assays and therapies for latent viral infection |
| 07/18/2006 | US7078165 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis |
| 07/18/2006 | US7078064 Antioxidation; reducing oxidative stresses; oral administering of mixture of glycyrrhzin, vitamin c, silymarin, lipoic acid and tocopherol |
| 07/18/2006 | US7078054 The capsule shell contains a migrateable component (other than glycerol) which is also present in the capsule filling. |
| 07/18/2006 | US7078050 White cream bacteriostats, fungicide as vehicle for drug; receptivity |
| 07/18/2006 | US7078044 Antiinflammatory agents; antiarthritic agents; antiscarring agents; isolated oligopeptide |
| 07/18/2006 | US7078043 Malaria vaccine |
| 07/18/2006 | US7078042 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 07/18/2006 | US7078041 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 07/18/2006 | US7078036 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 07/18/2006 | US7078035 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/18/2006 | US7078032 Delivery of therapeutic biologicals from implantable tissue matrices |
| 07/18/2006 | US7078027 Human endokine alpha |
| 07/18/2006 | US7078021 Dental products comprising bone growth enhancing peptide |
| 07/18/2006 | CA2307317C Tumor rejection antigen precursors, tumor rejecti0n antigens and uses thereof |
| 07/18/2006 | CA2224528C Stilbene compositions in the adamantyl group, compositions containing them and uses |
| 07/18/2006 | CA2195556C Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 07/13/2006 | WO2006074467A2 Glycopegylated granulocyte colony stimulating factor |
| 07/13/2006 | WO2006074409A1 Tripeptide and tetrapeptide sulfones |
| 07/13/2006 | WO2006074341A2 Novel use |
| 07/13/2006 | WO2006074279A1 Glycoconjugation using saccharyl fragments |
| 07/13/2006 | WO2006074249A1 Tripeptide and tetrapeptide thioethers |
| 07/13/2006 | WO2006074199A1 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/13/2006 | WO2006074182A2 Growth factor therapy mobilization of stem cells into the peripheral blood |
| 07/13/2006 | WO2006073971A2 Binding protein with a scaffold for varying specificity |
| 07/13/2006 | WO2006073889A2 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 07/13/2006 | WO2006073846A2 Methods for expression and purification of recombinant human growth hormone |
| 07/13/2006 | WO2006073786A2 Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
| 07/13/2006 | WO2006073734A2 Modulator of alpha-synuclein toxicity |
| 07/13/2006 | WO2006073625A2 Inhibition of li expression in mammalian cells |
| 07/13/2006 | WO2006073601A2 Methods and compositions for rna interference |
| 07/13/2006 | WO2006073508A1 Use of il-22 for the treatment of conditions of metabolic disorders |
| 07/13/2006 | WO2006073417A2 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 07/13/2006 | WO2006073410A1 Compositions, methods and devices for preparing less painful botulinum toxin formulations |
| 07/13/2006 | WO2006073254A1 Composition for prevention, treatment and diagnosis of chronic inflammatory airway diseases |
| 07/13/2006 | WO2006073181A1 Cell activator, cell death inhibitor and cell death promoter |
| 07/13/2006 | WO2006073119A1 Polypeptide and use of the same |
| 07/13/2006 | WO2006073052A1 Novel angiogensis inhibitor |
| 07/13/2006 | WO2006072888A2 Continuous administration of epitopes derived from protein present in atherosclerotic plaque for the treatment of atherosclerosis |
| 07/13/2006 | WO2006072639A1 Use of a cyclic undecapeptide for the preparation of a medicament for administration during myocardial ischaemic events |
| 07/13/2006 | WO2006072623A1 Local treatment of bone defects with matrix releasing bmp or pth |
| 07/13/2006 | WO2006072579A1 Pharmaceutically active antiviral peptides |
| 07/13/2006 | WO2006072561A1 X-ray structure of human fpps and use for selecting fpps binding compounds |
| 07/13/2006 | WO2006072249A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 07/13/2006 | WO2006072137A1 Treatment for autoimmune and inflammatory conditions |
| 07/13/2006 | WO2006058215A3 In situ method for treatment and repair of meniscal injuries |
| 07/13/2006 | WO2006053010A3 Use of antioxidants for gene modulation |
| 07/13/2006 | WO2006052129A3 Antibiotic drosocin derivatives |
| 07/13/2006 | WO2006049933A3 Compositions and methods for the treatment of obesity and sexual dysfunction |
| 07/13/2006 | WO2006047820A9 Use of calgranulin a and b in the promotion and inhibition of mineralized tissue formation |
| 07/13/2006 | WO2006044459A3 Prion protein binding materials and methods of use |
| 07/13/2006 | WO2006042002A3 Compositions and methods for treating disease |
| 07/13/2006 | WO2006020891A3 Chemokine combinations to mobilize progenitor/stem cells |
| 07/13/2006 | WO2006018652A3 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif |
| 07/13/2006 | WO2006016353A3 Elastase inhibitor in leukemia |
| 07/13/2006 | WO2006009525A3 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 07/13/2006 | WO2006008003A3 Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 1 (vpac1) |
| 07/13/2006 | WO2006006954A3 Modified fusion peptides derived from a p53 domain against malignant and/or transformed mammalian cells |
| 07/13/2006 | WO2006002422A3 Compounds for immunopotentiation |
| 07/13/2006 | WO2006002195A3 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 07/13/2006 | WO2005123109A3 Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use |
| 07/13/2006 | WO2005120475A3 Pharmaceutical composition for the treatment of bacterial infections and sepsis |
| 07/13/2006 | WO2005112978A3 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
| 07/13/2006 | WO2005110478A3 Combination therapy for treating fibrotic disorders |
| 07/13/2006 | WO2005094278A3 N-acylated chitinous polymers and methods of use thereof |
| 07/13/2006 | WO2005084710A3 Nanocell drug delivery system |
| 07/13/2006 | WO2005077416A3 Lipid rafts and clostridial toxins |
| 07/13/2006 | WO2005042699A3 Modified polypeptides with therapeutic activity and methods of use |
| 07/13/2006 | WO2004092197A8 Amyloid-specific peptides and uses thereof |
| 07/13/2006 | WO2004078908A3 Alpha-keto carbonyl calpain inhibitors |
| 07/13/2006 | WO2004060300A3 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 07/13/2006 | WO2004045535A3 Molecular interactions in neurons |
| 07/13/2006 | US20060156426 Transgenic mice containing ABC transporter-like ATPase gene disruptions |
| 07/13/2006 | US20060156423 Method of screening antiobesity agents and animal model of obesity |
| 07/13/2006 | US20060155234 Hemostatic dressing |
| 07/13/2006 | US20060155117 Novel preadipocyte factor-1-like polypeptides |
| 07/13/2006 | US20060155115 Multivalent T cell receptor complexes |
| 07/13/2006 | US20060155111 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 07/13/2006 | US20060155109 agonist; a memory function improving agent, appetite regulator; an uterine, renal, testis, spleen, heart, prostatic or skeletal muscle function improving agent; antiobesity agent, antiabetic |
| 07/13/2006 | US20060155108 Multiple branch peptide construction |
| 07/13/2006 | US20060155107 SSTR1-selective analogs |
| 07/13/2006 | US20060154976 Reducing the incidence of fibrosis by the co-administration of effective amounts of telmisartan and ramipril; strokes; cardiovascular disorders; organoprotective, tissue-protective, and vasculoprotective effects of combined treatment |
| 07/13/2006 | US20060154893 Exopolysaccharides delivery system for active molecules |
| 07/13/2006 | US20060154884 Use of a vegf receptor gener or gene product |
| 07/13/2006 | US20060154882 Methods for blocking adipocyte differentiation and triglyceride accumulation with g-alpha-i3 inhibitors |
| 07/13/2006 | US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 07/13/2006 | US20060154871 Peptides |
| 07/13/2006 | US20060154869 administering adiponectin, which inhibits the actions of TGFB and PDGF on hepatic stellate cells and thereby exerts effects of suppressing hepatic fibrosis and promoting the proliferation of normal hepatocytes; treating liver cirrhosis or chronic hepatitis |
| 07/13/2006 | US20060154868 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/13/2006 | US20060154867 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 07/13/2006 | US20060154866 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 07/13/2006 | US20060154865 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 07/13/2006 | US20060154864 Transcript factor and an Akt substrate related to transcriptional action of insulin and applications of same |
| 07/13/2006 | US20060154863 Methods and compositions for treating conditions |
| 07/13/2006 | US20060154862 Processes for preparing a polypeptide |
| 07/13/2006 | US20060154861 Method for screening substances capable of inhibiting the hyperplasia of pancreatic cells and/or the hypersecretion of insulin by pancreatic cells |